S&R Associates represented BofA Securities India Limited in connection with the delivery of a fairness opinion to the board of directors of Sanofi India Limited (“SIL”), a listed healthcare company, on the proposed demerger of its consumer healthcare business undertaking into its wholly-owned subsidiary, Sanofi Consumer Healthcare India Limited, pursuant to a scheme of arrangement.
The S&R team was led by partner Jabarati Chandra, and included associates Sushmita Sur and Ameesha Tripathi.
For reference, please see the stock exchange announcement below in relation to the transaction:
https://www.bseindia.com/xml-data/corpfiling/AttachLive/498d15ec-641c-4214-b6c7-272c8c43573e.pdf